HealthcareM&ASalix Pharmaceuticals to buy Santarus for $32/shareNov. 07, 2013 4:14 PM ETSalix Pharmaceuticals, Ltd. (SLXP) StockSNTS, SLXPBy: Colin Lokey, SA News Editor2 CommentsSalix Pharmaceuticals (NASDAQ:SLXP) will acquire Santarus (NASDAQ:SNTS) for $32/share, a 38% premium to today's close, valuing the company at ~$2.6B. (PR)Recommended For YouRelated StocksSymbolLast Price% ChgSLXP--Salix Pharmaceuticals, Ltd.Trending AnalysisTrending News